ADHD Drug Shortages Draw Attention In Congress, Court

23 Jan 2012

Lawmakers seek information from Shire, Novartis and the Drug Enforcement Administration as to the reason behind short supplies of some attention deficit/hyperactivity disorder drugs. A legal dispute over supply of an Adderall XR authorized generic is slated for trial in April.

Issues surrounding the short supply of some attention deficit/hyperactivity disorder drugs are getting attention in both the halls of Congress and a New York federal court.

Four House Democrats have requested information from Shire PLC and Novartis AG in a bid to determine whether...